Astrazeneca Pharma India Ltd Cash Flow Statement: Consolidated Financial Analysis & Historical Data (15 Years)

Cash Flow

Astrazeneca Phar Cash flow Statement

Figures in Cr

Standaloned Cash Flow Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Figures in INR Cr
Seasonal companies are compared with the same quarter last year

Compare Cash Flow Results of Astrazeneca Phar

Select Peers

Figures in Cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

156.36

1016.09

-860.00

-84.61%

Adjustment

76.41

-256.91

332.00

129.74%

Changes In working Capital

-103.22

56.79

-159.00

-281.76%

Cash Flow after changes in Working Capital

129.55

815.97

-686.00

-84.12%

Cash Flow from Operating Activities

65.36

659.75

-594.00

-90.09%

Cash Flow from Investing Activities

30.8

-71.34

101.00

143.17%

Cash Flow from Financing Activities

-65.59

-205.34

140.00

68.06%

Net Cash Inflow / Outflow

30.57

383.07

-353.00

-92.02%

Opening Cash & Cash Equivalents

505.57

112

393.00

351.40%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

536.14

495.07

41.00

8.30%

Cash Flow - Snapshot (Standalone) - Mar'25

YoY Growth in year ended Mar 2025 is 134.52% vs -52.19% in Mar 2024

Mar'25

Mar'24

Change(%)

Cash Flow from Operating Activities

65.36

27.87

134.52%